Antibody Drug Conjugates

Can the 'Pharmacy of the World' Survive Its Own Scandals?

In late September and early October 2025, children in the central Indian state of Madhya Pradesh began arriving at hospitals with the same grim trajectory:...

 June 08, 2026 | Analysis

Mabwell's First In Class Autoimmune Antibody 9MW5211 Wins China Clinical Trial Approval for IBD

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently...

 June 08, 2026 | News

Innovent's Arcotatug Tavatecan Meets Phase 3 Endpoint in Advanced Gastric Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

 June 05, 2026 | News

Samsung Epis Holdings Establishes First Global R&D Hub in Beijing to Advance ADC and Novel Drug Development

  Establishes its first global research base as part of strategic new business expansion under the holding company structure Ÿ  B...

 June 03, 2026 | News

Pfizer And Innovent Biologics Forge Global Oncology Alliance Covering 12 Cancer Programs

Pfizer Inc. and Innovent Biologics, Inc.  announced the companies have entered into a strategic global licensing and collaboration agreement for the r...

 June 01, 2026 | News

Ingenia Therapeutics Secures KRX Approval For IPO Amid Advancing TIE2 Targeted Pipeline

Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the company has receive...

 May 26, 2026 | News

LOTTE Biologics Expands Strategic Partnership With Ottimo Pharma To Advance OTP 01 Commercial Readiness

LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company developi...

 May 19, 2026 | News

Piramal Pharma Solutions Expands US ADC Manufacturing Capability With New Payload Linker Suite In Michigan

The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized...

 May 15, 2026 | News

GenScript Biotech Launches TurboCHO Protein Expression Kit To Accelerate Antibody Discovery Workflows

New kit offers researchers and development teams a meaningful advance in expression speed and output GenScript Biotech Corporation announced the laun...

 May 14, 2026 | News

Sichuan Kelun-Biotech Biopharmaceutical Secures China IND Clearance For PD 1 x VEGF Bispecific SKB118 In Advanced Solid Tumours

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical trial notice from t...

 May 14, 2026 | News

Mabwell Secures US FDA Clearance For First In Class Autoimmune Antibody 9MW5211

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the Investigation...

 May 11, 2026 | News

ACROBiosystems And SeromYx Partner To Advance Functional Profiling Of Anti CD20 Antibodies

ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collabora...

 May 01, 2026 | News

Prestige Biopharma IDC Files Patent For Next Generation Subcutaneous Antibody Delivery Platform

Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation ...

 April 24, 2026 | News

BioEngine Launches UltraFeed To Boost CHO Cell Productivity In Biologics Manufacturing

Shanghai BioEngine Sci-tech Co., Ltd. announced the launch of UltraFeed, a next-generation fed-batch supplement designed to elevate CHO cell...

 April 24, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close